Norman Huebert

1.4k total citations
40 papers, 1.1k citations indexed

About

Norman Huebert is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Norman Huebert has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Norman Huebert's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Epilepsy research and treatment (6 papers). Norman Huebert is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Epilepsy research and treatment (6 papers). Norman Huebert collaborates with scholars based in United States, France and Sweden. Norman Huebert's co-authors include Klaus D. Haegele, Paul J. Schechter, Zhengyin Yan, Jeffrey Grove, Nina Hanke, Albert Sjoerdsma, Gary W. Caldwell, Josiane Schoun, J. Hardenberg and John Mumford and has published in prestigious journals such as Analytical Chemistry, Neurology and Analytical Biochemistry.

In The Last Decade

Norman Huebert

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman Huebert United States 21 356 296 283 186 176 40 1.1k
Ana I. Loureiro Portugal 21 394 1.1× 340 1.1× 226 0.8× 209 1.1× 134 0.8× 60 1.6k
Anthony J. Streeter United States 17 352 1.0× 421 1.4× 238 0.8× 269 1.4× 362 2.1× 39 1.5k
Maria João Bonifácio Portugal 21 605 1.7× 491 1.7× 360 1.3× 271 1.5× 123 0.7× 85 1.7k
U. Breyer-Pfaff Germany 20 357 1.0× 119 0.4× 118 0.4× 139 0.7× 383 2.2× 55 1.1k
Lyndon Wright Portugal 19 420 1.2× 235 0.8× 146 0.5× 108 0.6× 92 0.5× 49 1.4k
Madeleine Antonsson Sweden 14 280 0.8× 100 0.3× 133 0.5× 132 0.7× 175 1.0× 20 1.1k
R. Massingham Belgium 27 966 2.7× 104 0.4× 614 2.2× 91 0.5× 106 0.6× 86 2.1k
Tadahiko Karasawa Japan 19 319 0.9× 300 1.0× 385 1.4× 206 1.1× 48 0.3× 63 983
John G. Page United States 21 532 1.5× 107 0.4× 96 0.3× 234 1.3× 481 2.7× 43 1.7k

Countries citing papers authored by Norman Huebert

Since Specialization
Citations

This map shows the geographic impact of Norman Huebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Huebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Huebert more than expected).

Fields of papers citing papers by Norman Huebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Huebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Huebert. The network helps show where Norman Huebert may publish in the future.

Co-authorship network of co-authors of Norman Huebert

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Huebert. A scholar is included among the top collaborators of Norman Huebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Huebert. Norman Huebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Fengbin, Guozhang Xu, Michael D. Gaul, et al.. (2019). Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 29(15). 1974–1980. 18 indexed citations
2.
Winters, Michael P., Zhihua Sui, Mark J. Wall, et al.. (2018). Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes. Bioorganic & Medicinal Chemistry Letters. 28(5). 841–846. 18 indexed citations
3.
Kreutter, K. D., Tianbao Lu, Lily Lee, et al.. (2008). Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif. Bioorganic & Medicinal Chemistry Letters. 18(9). 2865–2870. 24 indexed citations
4.
Chen, Yanmin, et al.. (2008). Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct‐cannulated rats. Biopharmaceutics & Drug Disposition. 29(4). 219–230. 1 indexed citations
5.
Peng, Sean, et al.. (2008). Improved Pharmacokinetic and Bioavailability Support of Drug Discovery Using Serial Blood Sampling in Mice. Journal of Pharmaceutical Sciences. 98(5). 1877–1884. 39 indexed citations
6.
7.
Chen, Yanmin, Stephen Eisennagel, Malini Dasgupta, et al.. (2008). Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog andin vitrodrug metabolism. Biopharmaceutics & Drug Disposition. 29(3). 127–138. 1 indexed citations
8.
Santulli, Rosemary J., William A. Kinney, Shyamali Ghosh, et al.. (2007). Studies with an Orally Bioavailable αV Integrin Antagonist in Animal Models of Ocular Vasculopathy: Retinal Neovascularization in Mice and Retinal Vascular Permeability in Diabetic Rats. Journal of Pharmacology and Experimental Therapeutics. 324(3). 894–901. 41 indexed citations
9.
Huebert, Norman, et al.. (2006). Human oral drugs absorption is correlated to their in vitro uptake by brush border membrane vesicles. International Journal of Pharmaceutics. 336(1). 115–121. 8 indexed citations
10.
Yan, Zhengyin, Jian Li, Norman Huebert, et al.. (2005). DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES. Drug Metabolism and Disposition. 33(6). 706–713. 79 indexed citations
11.
Yan, Zhengyin, et al.. (2005). Rapid detection and characterization of minor reactive metabolites using stable‐isotope trapping in combination with tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 19(22). 3322–3330. 49 indexed citations
12.
Huebert, Norman, et al.. (1997). Analysis of 2-difluoromethyl-dl-ornithine in human plasma, cerebrospinal fluid and urine by cation-exchange high-performance liquid chromatography. Journal of Chromatography A. 762(1-2). 293–298. 14 indexed citations
13.
14.
Huebert, Norman, et al.. (1996). Simultaneous measurement of dolasetron and its major metabolite, MDL 74,156, in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 685(2). 291–297. 6 indexed citations
15.
Ducray, Patricia Sanwald, et al.. (1995). Isocratic high-performance liquid chromatographic method for the separation of testosterone metabolites. Journal of Chromatography B Biomedical Sciences and Applications. 672(2). 207–215. 44 indexed citations
16.
Huebert, Norman, et al.. (1994). Kinetics and metabolism of p-tyramine during monoamine oxidase inhibition by mofegiline. Clinical Pharmacology & Therapeutics. 56(5). 537–542. 7 indexed citations
17.
Huebert, Norman, et al.. (1994). The Measurement of β-Phenylethylamine in Human Plasma and Rat Brain. Analytical Biochemistry. 221(1). 42–47. 12 indexed citations
18.
Ben‐Menachem, E., et al.. (1989). The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.. British Journal of Clinical Pharmacology. 27(S1). 79S–85S. 75 indexed citations
19.
Haegele, Klaus D., et al.. (1988). Pharmacokinetics of vigabatrin: Implications of creatinine clearance. Clinical Pharmacology & Therapeutics. 44(5). 558–565. 58 indexed citations
20.
Huebert, Norman, Michael G. Palfreyman, & Klaus D. Haegele. (1983). A comparison of the effects of reversible and irreversible inhibitors of aromatic L-amino acid decarboxylase on the half-life and other pharmacokinetic parameters of oral L-3,4-dihydroxyphenylalanine.. Drug Metabolism and Disposition. 11(3). 195–200. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana I. Loureiro Breakdown of academic impact, for papers by Anthony J. Streeter Breakdown of academic impact, for papers by Maria João Bonifácio Breakdown of academic impact, for papers by U. Breyer-Pfaff Breakdown of academic impact, for papers by Lyndon Wright Breakdown of academic impact, for papers by Madeleine Antonsson Breakdown of academic impact, for papers by R. Massingham Breakdown of academic impact, for papers by Tadahiko Karasawa Breakdown of academic impact, for papers by John G. Page
Rankless by CCL
2026